Quantitative EEG (QEEG) Measures Differentiate Parkinson's Disease (PD) Patients from Healthy Controls (HC).
Objectives:To find out which Quantitative EEG (QEEG) parameters could best distinguish patients with Parkinson's disease (PD) with and without Mild Cognitive Impairment from healthy individuals and to find an optimal method for feature selection.Background:Certain QEEG parameters have been seen to be associated with dementia in Parkinson's and Alzheimer's disease. Studies have also shown some parameters to be dependent on the stage of the disease. We wanted to investigate the differences in high-resolution QEEG measures between groups of PD patients and healthy individuals, and come up with a small subset of features that could accurately distinguish between the two groups.Methods:High-resolution 256-channel EEG were recorded in 50 PD patients (age 68.8 ± 7.0 year; female/male 17/33) and 41 healthy controls (age 71.1 ± 7.7 year; female/male 20/22). Data was processed to calculate the relative power in alpha, theta, delta, beta frequency bands across the different regions of the brain. Median, peak frequencies were also obtained and alpha1/theta ratios were calculated. Machine learning methods were applied to the data and compared. Additionally, penalized Logistic regression using LASSO was applied to the data in R and a subset of best-performing features was obtained.Results:Random Forest and LASSO were found to be optimal methods for feature selection. A group of six measures selected by LASSO was seen to have the most effect in differentiating healthy individuals from PD patients. The most important variables were the theta power in temporal left region and the alpha1/theta ratio in the central left region.Conclusion:The penalized regression method applied was helpful in selecting a small group of features from a dataset that had high multicollinearity.
Department of Neurology, University Hospital BaselBasel, Switzerland; Department of Mathematics and Computer Science, University of BaselBasel, Switzerland.
Menorca
M
Chaturvedi
Department of Neurology, University Hospital Basel Basel, Switzerland.
Florian
F
Hatz
Department of Neurology, University Hospital Basel Basel, Switzerland.
Ute
U
Gschwandtner
Department of Neurology, University Hospital BaselBasel, Switzerland; Department of Mathematics and Computer Science, University of BaselBasel, Switzerland.
Jan G
JG
Bogaarts
Department of Neurology, University Hospital Basel Basel, Switzerland.
Antonia
A
Meyer
Department of Neurology, University Hospital Basel Basel, Switzerland.
Peter
P
Fuhr
Department of Mathematics and Computer Science, University of Basel Basel, Switzerland.
Volker
V
Roth
Parkinson's disease; Parkinson's disease dementia; QEEG; cognitive decline; machine learning; neurodegenerative disorders